March 2026

The question of whether Ozempic is dangerous often arises when medical options and concerns get mixed up. On the one hand, there are people who benefit from it within healthcare. On the other hand, stories circulate about intense complaints, disappointing results and resources with unclear origins. “Dangerous” is rarely a

Wegovy and Saxenda often pop up first when medication is considered for overweight or obesity. Online, the conversation then quickly turns to “which drug gives the most weight loss”. In practice, a responsible choice usually revolves around something else: what is medically appropriate, what is maintainable in daily life and

Hoping to notice results quickly is understandable, especially if previous attempts required a lot of effort and gave little guidance. At the same time, “it works” with Mounjaro means less appetite for some, while others notice that meals fall differently or that blood sugar problems calm down. Visible difference on the scales often follows later. That

Ozempic is usually only reimbursed from the basic health insurance in the Netherlands for type 2 diabetes mellitus, and then subject to conditions. When used with the main objective of weight loss (without appropriate diabetes indication), reimbursement is usually not an issue. At the same time, confusion regularly arises because Ozempic is often linked to weight loss in conversations and (social) media, while health insurers mainly

An Ozempic pen once pricked requires different storage choices than an unopened pen. It is precisely then that uncertainty often arises, for instance about fridge versus room temperature, a pen that has become warm or an opening date that is no longer sharp. Good storage arrangements help keep operations predictable and avoid unnecessary risk. With a

You hear the name more and more often: Mounjaro. From acquaintances, on social media, or maybe from your GP. But what exactly is it, who is it for, and what makes it different from other weight-loss medications? What is Mounjaro? Mounjaro is a relatively new medication with the active ingredient tirzepatide. The medication is designed to